SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-041132
Filing Date
2022-11-14
Accepted
2022-11-14 06:10:56
Documents
12
Period of Report
2022-11-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10044032_8k.htm   iXBRL 8-K 33826
  Complete submission text file 0001140361-22-041132.txt   169589

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20221110.xsd EX-101.SCH 3875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20221110_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20221110_pre.xml EX-101.PRE 16051
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10044032_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 221379654
SIC: 2834 Pharmaceutical Preparations